PGNY: Stable demand, expanding products, and strong cost control support robust growth outlook
Category: Business
Share
Archive
Like
Seasonal utilization softness was noted but is seen as normal, with stable demand expected for the year. Growth is driven by expanding market acceptance, new risk-based products for smaller employers, and ongoing cost containment. Early commitments support confidence in meeting the one million lives target.
Based on Progyny, Inc. [PGNY] Wells Fargo 21st Annual Healthcare Conference Audio Transcript — Sep. 8 2026
A note on cookies
Newshunt uses essential cookies to keep you signed in and to remember your language and country, so the site works the way you expect. With your permission, we'd also like to use analytics cookies to understand how people use Newshunt and improve it over time.
Accepting only affects analytics. To learn more, view our Privacy Policy or Terms & Conditions.
(0)Comments